Antismoking treatment ‘Champix’ recording KRW 12.6 billion only in 1st quarter
The Pfizer Pharmaceuticals Korea’s antismoking treatment, ‘Champix(varenicline),’ has shown a fierce growth together with the government’s antismoking treatment support project.
According to the IMS data of the 1st quarter this year, Champix recorded prescriptions of KRW 12.6 billion, significa...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
